Pilot-testing a Perinatal Palliative Care Intervention Program (PPC-pilot)

Vrije Universiteit Brussel

Status

Enrolling

Conditions

Perinatal Palliative Care

Life-limiting Fetal Diagnosis

Life-limiting Neonatal Diagnosis

Treatments

Behavioral: Perinatal palliative care

Study type

Interventional

Funder types

Other

Identifiers

NCT06456034

PPC-pilot

Details and patient eligibility

About

The objective of this pilot trial is to implement a new perinatal palliative care intervention program tailored to the Flemish context, which aims to provide care to parents who receive a severe foetal/neonatal diagnosis for their (unborn) child and to their healthcare providers. Additionally, we aim to evaluate the feasibility and preliminary effectiveness by comparing measured variables to the baseline measurement done in the same hospital wards beforehand.

Enrollment

20 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

Parents:
- who receive a severe foetal diagnosis for their unborn child and decide to continue the pregnancy after 20 weeks of gestation , or
- who receive a severe foetal diagnosis for their unborn child after 20 weeks gestation and decide to terminate the pregnancy (with or without feticide) resulting in the stillbirth of their child
Parents who receive a severe neonatal diagnosis for their live-born infant in the first week after birth

Additional inclusion criteria for parents:

Parents are either Dutch speaking, or are willing to participate with support from a (phone or real life) interpreter, in collaboration with the "Agentschap Integratie & Inburgering"
Parents are older than 18
Parents are not suffering from an officially diagnosed psychiatric disorder prior to receiving the severe diagnosis of their child
Parents are deemed (emotionally) approachable for the current study by the treating physician

For each family included in the pilot study, the physicians and nurses/midwives who will be/are most closely involved in the care of the infant and the parents will also be asked to participate. If healthcare providers refuse to provide informed consent to participate in the study, their data will be deemed as missing for that case (parental outcomes are considered as the primary outcome measures).